OPHLY
Price:
$3.41
Market Cap:
$745.66B
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON ta...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-10-02
Stock Exchange
PNK
Ticker
OPHLY
According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 7.93. This represents a change of -35.11% compared to the average of 12.22 of the last 4 quarters.
The mean historical PE Ratio of Ono Pharmaceutical Co., Ltd. over the last ten years is 36.99. The current 7.93 PE Ratio has changed 2.04% with respect to the historical average. Over the past ten years (40 quarters), OPHLY's PE Ratio was at its highest in in the September 2015 quarter at 154.74. The PE Ratio was at its lowest in in the March 2015 quarter at -131.72.
Average
36.99
Median
21.39
Minimum
9.26
Maximum
110.93
Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.22%
Maximum Annual PE Ratio = 110.93
Minimum Annual Increase = -78.35%
Minimum Annual PE Ratio = 9.26
Year | PE Ratio | Change |
---|---|---|
2024 | 9.26 | -22.67% |
2023 | 11.97 | -36.66% |
2022 | 18.90 | -1.15% |
2021 | 19.13 | -8.86% |
2020 | 20.98 | -3.74% |
2019 | 21.80 | -35.80% |
2018 | 33.96 | 55.12% |
2017 | 21.89 | -78.35% |
2016 | 101.11 | -8.86% |
2015 | 110.93 | 138.22% |
The current PE Ratio of Ono Pharmaceutical Co., Ltd. (OPHLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.38
5-year avg
16.05
10-year avg
36.99
Ono Pharmaceutical Co., Ltd.’s PE Ratio is less than Santen Pharmaceutical Co., Ltd. (20.93), less than GSK plc (21.76), less than Grifols, S.A. (34.49), less than Pfizer Inc. (35.53), less than Sanofi (25.51), greater than Organon & Co. (2.92), less than Horizon Therapeutics Public Limited Company (51.10), less than GSK plc (21.76), less than AstraZeneca PLC (31.35), less than Roche Holding AG (18.89), less than Novartis AG (11.33), less than Merck & Co., Inc. (20.73), greater than Bristol-Myers Squibb Company (-16.14), less than Gilead Sciences, Inc. (929.81), less than Amgen Inc. (33.58), less than Johnson & Johnson (23.91), less than AbbVie Inc. (62.10),
Company | PE Ratio | Market cap |
---|---|---|
20.93 | $3.50B | |
21.76 | $67.49B | |
34.49 | $5.93B | |
35.53 | $151.34B | |
25.51 | $120.51B | |
2.92 | $3.79B | |
51.10 | $0 | |
21.76 | $69.43B | |
31.35 | $205.57B | |
18.89 | $225.56B | |
11.33 | $192.42B | |
20.73 | $251.57B | |
-16.14 | $117.15B | |
929.81 | $117.09B | |
33.58 | $142.17B | |
23.91 | $351.15B | |
62.10 | $317.73B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ono Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the highest PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 3-year average PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 5-year average PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLY)?
How does the current PE Ratio for Ono Pharmaceutical Co., Ltd. (OPHLY) compare to its historical average?